Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with BIOA: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
BIOA
BioAge Labs, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
BIOA
BioAge Labs, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No disclosed counterparties: BIOA.
Only BIOA
0
None
Role chip = supplier or customer
Source: SEC EDGAR
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
BIOA
BioAge Labs, Inc.
Change
5.30
▼
−4.38%
· post 5.30
Closed
Nov 6 '26
Mkt cap
$254.3M
Revenue
$298,000
Q3 FY26
Revenue
$9M
FY25
vs
Compare
Closed
Nov 6 '26
LLY
ELI Lilly & Co
vs
BIOA
BioAge Labs, Inc.
1,360.90
▼
−0.28%
post 1,358.90
Price
5.30
▼
−4.38%
post 5.30
$1.2T
Mkt cap
$254.3M
Q3 FY26
$24.4B
Revenue
$298,000
Q3 FY26
FY25
$65.2B
Revenue
$9M
FY25
Change
Change
LLY
1,360.90
▼
−0.28%
vs
BIOA
5.30
▼
−4.38%
Closed
Nov 6 '26